Analysis of Drug-Related Problems in Outpatient HIV Patient Based On PCNE Criteria: A Literature Review

Share this article Share via WhatsApp

Article metrics

OJS usage and citation sources
Abstract views11OJS
Article downloads4OJS
Crossref citations—Unavailable
Google Scholar citations—Not verified

Views and downloads are recorded by OJS; statistics processing may be delayed. A dash means the source count is unavailable. Search Google Scholar

Main Article Content

Anisah Luthfitah
Hidayah Karuniawati

Abstract

HIV (Human Immunodeficiency Virus) is a major health problem in the world and is a chronic disease that can be managed with antiretrovirals, but it also increases the risk of comorbidities. This review assesses drug-related problems (DRPs) in HIV patients using the Pharmaceutical Care Network Europe (PCNE) classification. A systematic search for articles published in the last 10 years was conducted using Google Scholar, Scopus, and PubMed. Three articles met the inclusion criteria, reporting DRP frequencies ranging from 58 to 183 cases, with 1,605 DRP causes identified in one of the studies. The most common problem domain was treatment safety, namely the incidence of adverse drug reactions with a total of 9 cases (15.5%), 87 cases (47.5%), and 475 cases (58.1%). The domains causing DRP that were frequently found were "Patient cannot understand instructions correctly" (C7.10) with 321 cases (19.1%), Patient non-compliance (C7.1) with 320 cases (19%), and inappropriate monitoring of therapy (C9.1) with 141 cases (8.4%). In conclusion, DRPs represent a major burden in HIV outpatient care, largely due to adverse drug reactions and patient-related factors. The role of the clinical pharmacist is critical to the identification, prevention, and resolution of DRP to optimize long-term antiretroviral therapy

Article Details

Section

Review Article

Author Biography

Hidayah Karuniawati, Muhammadiyah Surakarta University, Muhammadiyah University of Surakarta

Department of Pharmacy, Faculty of Pharmacy, Muhammadiyah University of Surakarta, Surakarta, Indonesia

How to Cite

Analysis of Drug-Related Problems in Outpatient HIV Patient Based On PCNE Criteria: A Literature Review. (2026). Journal of Pharmaceutical and Sciences, 9(4), 3488-3498. https://doi.org/10.36490/journal-jps.com.v9i4.1711

References

[1] Unaids, “People living with HIV — Thematic briefing note — 2024 global AIDS update The Urgency of Now: AIDS at a Crossroads,” 2024, Accessed: Jun. 06, 2026. [Online]. Available: https://aidsinfo.unaids.org/

[2] Kementerian Kesehatan Republik Indonesia, “Berani Tes, Berani Lindungi Diri, Kemenkes Targetkan Eliminasi HIV dan IMS Tahun 2030.” Accessed: Jun. 11, 2026. [Online]. Available: https://kemkes.go.id/id/berani-tes-berani-lindungi-diri-kemenkes-targetkan-eliminasi-hiv-dan-ims-tahun-2030

[3] X. F. Ni, C. S. Yang, Y. M. Bai, Z. X. Hu, and L. L. Zhang, “Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review,” Front. Pharmacol., vol. 12, no. August, p. 698907, Aug. 2021, doi: 10.3389/fphar.2021.698907.

[4] E. Kara, A. Ç. İnkaya, D. A. Y. D. I. N. Hakli, K. Demirkan, and S. Ünal, “Polypharmacy and drug-related problems among people living with hiv/aids: A single-center experience,” Turkish J. Med. Sci., vol. 49, no. 1, pp. 222–229, 2019, doi: 10.3906/sag-1807-295.

[5] Pharmaceutical Care Network Europe Association (PCNE), “PCNE Classification for Drug-Related Problems V9.1,” PCNE Assoc., vol. 1, no. 2, pp. 22–28, 2020, [Online]. Available: http://www.pcne.org/upload/files/15_PCNE_classification_V4-00.pdf

[6] M. F. Che Pa, N. Tiang Koi, A. Misnan, F. H. Islahudin, and M. Makmor-Bakry, “Drug-Related Problems in HIV Treatment Failure.,” Cureus, vol. 16, no. 9, p. e69838, Sep. 2024, doi: 10.7759/cureus.69838.

[7] C. Gopinath, V. Sravani, M. M. Rao, and D. Girirajasekhar, “Screening of Drug Related Problems in HIV Patients Receiving Anti Retroviral Therapy,” J. Drug Deliv. Ther., vol. 8, no. 3, pp. 20–28, 2018, doi: 10.22270/jddt.v8i3.1754.

[8] S. Adiana and D. Maulina, “Klasifikasi Permasalahan Terkait Obat (Drug Related Problem/DRPs): Review,” Indones. J. Heal. Sci., vol. 2, no. 2, pp. 54–58, 2022, doi: 10.54957/ijhs.v2i2.238.

[9] K. Munenu, “Drug related problems associated with anti-retroviral therapy of HIV/AIDS patients at Ndola Central Hospital,” 2017, Accessed: May 12, 2026. [Online]. Available: https://dspace.unza.zm/handle/123456789/5707

[10] R. I. Aderemi-Williams, S. O. Nduaguba, E. M. Akoji, P. U. Ogbo, and I. O. Abah, “Drug therapy problems identified among patients receiving antiretroviral treatment in a HIV clinic: a prospective study in North Central, Nigeria,” Pan Afr. Med. J., vol. 40, p. 233, Sep. 2021, doi: 10.11604/PAMJ.2021.40.233.28160.

[11] I. O. Putrinda, Y. P. Sukmawan, and V. Nurviana, “Evaluasi Penggunaan Obat dan Efek Sampingnya pada Penderita HIV/AIDS di Salah Satu Rumah Sakit di Kota Tasikmalaya,” Pros. Semin. Nas. Disem., vol. 2, pp. 91–100, 2022.

[12] O. N. Putra, “A cross sectional survey of side effects of antiretroviral (ARV) in outpatients HIV by Naranjo Algorithm,” J. Ilm. Farm., vol. 17, no. 1, pp. 34–45, 2021, doi: 10.20885/jif.vol17.iss1.art4.

[13] J. . Aberg, C. . Lacy, L. . Amstrong, M. . Goldman, and L. . Lance, Drug Information Handbook, 17th ed. Lexi-Comp for the American Pharmacists Association, 2009.

[14] T. Barus, Y. Anwar, and D. Ginting, “Evaluasi Efek Samping Obat Antoretroviral dan Penatalaksanaannya Pada Pasien HIV/AIDS di Puskesmas Kecamatan Pejaringan Jakarta Utara Periode Tahun 2013 – 2015,” Soc. Clin. Pharm. Indones. J., vol. 2, no. 1, pp. 29–37, 2017, doi: 10.52447/SCPIJ.V2I1.817.

[15] N. Moses et al., “Prevalence and factors associated with adverse drug reactions among patients on highly active antiretroviral therapy at a tertiary hospital in south western Uganda: A cross-sectional study,” PLoS One, vol. 20, no. 4, p. e0321015, Apr. 2025, doi: 10.1371/JOURNAL.PONE.0321015.

[16] Z. Bashir, M. Zayyad, N. Danjuma, and A. Biambo, “Impact of pharmaceutical care interventions on the resolution of drug therapy problems among HIV-infected patients on second-line antiretroviral therapy in a Nigerian tertiary healthcare facility,” West African J. Pharm., vol. 37, no. 1, pp. 161–169, 2026, Accessed: Jun. 29, 2026. [Online]. Available: https://wapcpjournal.org.ng/index.php/home/article/view/449/276

[17] C. G. R. C. R. C. Molino, R. C. Carnevale, A. T. Rodrigues, P. Moriel, and P. G. Mazzola, “HIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problems,” Saudi Pharm. J., vol. 25, no. 5, pp. 724–733, Jul. 2017, doi: 10.1016/j.jsps.2016.11.004.

[18] Y. Lailulo, M. Kitenge, S. Jaffer, O. Aluko, and P. S. Nyasulu, “Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis,” Syst. Rev., vol. 9, no. 1, p. 292, Dec. 2020, doi: 10.1186/S13643-020-01524-1.

[19] N. Yuniarti, M. A. Yuswar, and E. K. Untari, “Kejadian interaksi obat pada pasien HIV/AIDS yang menerima antiretroviral di RSUD Dr. Soedarso Pontianak periode 2018,” J. Cerebellum, vol. 6, no. 1, pp. 6–11, Nov. 2020, doi: 10.26418/JC.V6I1.43345.

[20] P. Courlet et al., “Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV,” Open Forum Infect. Dis., vol. 6, no. 12, p. ofz531, Dec. 2019, doi: 10.1093/OFID/OFZ531.

[21] M. Arifiani and Z. Cholisoh, “Kejadian Drug-Related Problems (DRPs) Pada Pasien HIV dengan koinfeksi Tuberkulosis di Rumah Sakit Rujukan Jawa Tengah, Indonesia,” J. Pharm. Sci., pp. 1750–1759, Jun. 2026, doi: 10.36490/JOURNAL-JPS.COM.V9I2.1629.

[22] N. Rita, “Hubungan Kepatuhan Odha Dengan Keberhasilan Terapi Antiretroviral (Arv),” J. Kesehat. Lentera ’Aisyiyah, vol. 2, no. 1, pp. 42–47, Jun. 2019, Accessed: Aug. 03, 2026. [Online]. Available: https://jurnal.politasumbar.ac.id/index.php/jl/article/view/29/16

[23] F. N. Makualaina, “Faktor Penyebab Ketidak Patuhan Pasien Dalam Terapi Obat ARV di Puskesmas Harapan,” SBY Proc., vol. 4, no. 1, pp. 197–204, Aug. 2024, Accessed: Jun. 30, 2026. [Online]. Available: https://jurnal.stikesbethesda.ac.id/index.php/p/article/view/568

[24] A. P. Windiramadhan, W. N. Carsita, and S. Rahayu, “Hubungan Kepatuhan Obat ARV Dengan Kualitas Hidup Orang Dengan HIV/AIDS,” J. Keperawatan Sriwij., vol. 11, no. 1, pp. 1–7, 2024, doi: 10.24036/perspektif.v8i2.1083.

[25] I. B. Waskito, D. W. S. R. Wardani, and S. Susianti, “Pengetahuan Berhubungan Dengan Kepatuhan ODHA Dalam Menjalani Terapi Antiretroviral,” J. Penelit. Perawat Prof., vol. 5, no. 2, pp. 803–810, 2023.

[26] K. Wi. Astuti and S. C. Yowani, Pengantar Ilmu Komunikasi di Bidang Farmasi. Sumatera Barat: Mafy Media Literasi Indonesia, 2025. [Online]. Available: https://penerbitmafy.com/wp-content/uploads/2025/08/PENGANTAR-ILMU-KOMUNIKASI-DI-BIDANG-FARMASI.pdf

[27] Andhika, W. Wirawan, and M. Tamrin T, “Evaluasi Penggunaan Obat Antiretroviral Pada Pasien Odha (Orang Dengan Hiv Aids) Di Rumah Sakit Umum Undata Palu Provinsi Sulawesi Tengah,” Ags, no. 2, p. 1558, 2017.

[28] A. N. Marissa, A. A. Maqfirah, A. U. Hanifah, M. A. Priscilla, and F. Amalia, “Analisis Ketimpangan Akses Pelayanan Kesehatan Antara Kawasan Barat dan Timur Indonesia,” J. Kesehat. Tambusai, vol. 7, no. 1, pp. 1103–1114, Mar. 2026, doi: 10.31004/JKT.V7I1.53077.

[29] S. Maimanah, Y. D. Andarini, and N. M. Kusumaningtyas, “Identifikasi Drug Related Problems (Drps) pada Pasien Diabetes Mellitus Tipe 2 Komplikasi Hipertensi di Rsup Dr. Soeradji Tirtonegoro Klaten Tahun 2018,” Pharmasipha, vol. 4, no. 2, pp. 48–56, Sep. 2020, doi: 10.21111/PHARMASIPHA.V4I2.4961.

[30] D. H. Herlina, O. S. Abdillah, A. O. Anggraini, V. F. P. Kuncoro, A. P. Febriani, and E. Latifah, “Peran Apoteker dalam Pelayanan Paliatif untuk Meningkatkan Kualitas Hidup pada Pasien Hiv Stadium Akhir,” FASKES J. Farm. Kesehatan, dan Sains, vol. 2, no. 1, pp. 154–167, Jul. 2024, doi: 10.32665/FASKES.V2I1.3240.

[31] A. Ahmed, M. Tanveer, J. A. Dujaili, L. H. Chuah, F. K. Hashmi, and A. Awaisu, “Pharmacist-involved antiretroviral stewardship programs in people living with HIV/AIDS: a systematic reviewQ1AIDS Patient Care and STDs; H-Index: 100SJR: Q1 CORE: NA ABDC: NA FT50: NA 2AIDS Patient Care and STDs; H-Index: 100VHB: NA FNEGE: NA…,” journals.sagepub.com, vol. 37, no. 1, pp. 31–52, Jan. 2023, doi: 10.1089/APC.2022.0192.

[32] R. S. Handayani, Y. Yuniar, A. L. Susyanty, H. Lestary, and S. Sugiharti, “Gambaran Peran Apoteker sebagai Konselor dalam Pengobatan HIV-AIDS pada Ibu dan Anak,” Media Penelit. dan Pengemb. Kesehat., vol. 28, no. 4, pp. 229–238, Dec. 2018, doi: 10.22435/MPK.V28I4.329.

Most read articles by the same author(s)